z-logo
Premium
Superparamagnetic iron oxide nanoparticles regulate smooth muscle cell phenotype
Author(s) -
Angelopoulos Ioannis,
Southern Paul,
Pankhurst Quentin A.,
Day Richard M.
Publication year - 2016
Publication title -
journal of biomedical materials research part a
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.849
H-Index - 150
eISSN - 1552-4965
pISSN - 1549-3296
DOI - 10.1002/jbm.a.35780
Subject(s) - calponin , microbiology and biotechnology , actin , materials science , phenotype , cell , biophysics , smooth muscle , vascular smooth muscle , cytoplasm , vesicle , nanotechnology , chemistry , biology , biochemistry , gene , endocrinology , membrane
Superparamagnetic iron oxide nanoparticles (SPION) are used for an increasing range of biomedical applications, from imaging to mechanical actuation of cells and tissue. The aim of this study was to investigate the loading of smooth muscle cells (SMC) with SPION and to explore what effect this has on the phenotype of the cells. Adherent human SMC were loaded with ∼17 pg of unconjugated, negatively charged, 50 nm SPION. Clusters of the internalized SPION particles were held in discrete cytoplasmic vesicles. Internalized SPION did not cause any change in cell morphology, proliferation, metabolic activity, or staining pattern of actin and calponin, two of the muscle contractile proteins involved in force generation. However, internalized SPION inhibited the increased gene expression of actin and calponin normally observed when cells are incubated under differentiation conditions. The observed change in the control of gene expression of muscle contractile apparatus by SPION has not previously been described. This finding could offer novel approaches for regulating the phenotype of SMC and warrants further investigation. © 2016 The Authors Journal of Biomedical Materials Research Part A Published by Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 2412–2419, 2016.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here